Co-opts GBF1 and CERT to Acquire Host Sphingomyelin for Distinct Roles during Intracellular Development
The obligate intracellular pathogen Chlamydia trachomatis replicates within a membrane-bound inclusion that acquires host sphingomyelin (SM), a process that is essential for replication as well as inclusion biogenesis. Previous studies demonstrate that SM is acquired by a Brefeldin A (BFA)-sensitive vesicular trafficking pathway, although paradoxically, this pathway is dispensable for bacterial replication. This finding suggests that other lipid transport mechanisms are involved in the acquisition of host SM. In this work, we interrogated the role of specific components of BFA-sensitive and BFA-insensitive lipid trafficking pathways to define their contribution in SM acquisition during infection. We found that C. trachomatis hijacks components of both vesicular and non-vesicular lipid trafficking pathways for SM acquisition but that the SM obtained from these separate pathways is being utilized by the pathogen in different ways. We show that C. trachomatis selectively co-opts only one of the three known BFA targets, GBF1, a regulator of Arf1-dependent vesicular trafficking within the early secretory pathway for vesicle-mediated SM acquisition. The Arf1/GBF1-dependent pathway of SM acquisition is essential for inclusion membrane growth and stability but is not required for bacterial replication. In contrast, we show that C. trachomatis co-opts CERT, a lipid transfer protein that is a key component in non-vesicular ER to trans-Golgi trafficking of ceramide (the precursor for SM), for C. trachomatis replication. We demonstrate that C. trachomatis recruits CERT, its ER binding partner, VAP-A, and SM synthases, SMS1 and SMS2, to the inclusion and propose that these proteins establish an on-site SM biosynthetic factory at or near the inclusion. We hypothesize that SM acquired by CERT-dependent transport of ceramide and subsequent conversion to SM is necessary for C. trachomatis replication whereas SM acquired by the GBF1-dependent pathway is essential for inclusion growth and stability. Our results reveal a novel mechanism by which an intracellular pathogen redirects SM biosynthesis to its replicative niche.
Vyšlo v časopise:
Co-opts GBF1 and CERT to Acquire Host Sphingomyelin for Distinct Roles during Intracellular Development. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002198
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002198
Souhrn
The obligate intracellular pathogen Chlamydia trachomatis replicates within a membrane-bound inclusion that acquires host sphingomyelin (SM), a process that is essential for replication as well as inclusion biogenesis. Previous studies demonstrate that SM is acquired by a Brefeldin A (BFA)-sensitive vesicular trafficking pathway, although paradoxically, this pathway is dispensable for bacterial replication. This finding suggests that other lipid transport mechanisms are involved in the acquisition of host SM. In this work, we interrogated the role of specific components of BFA-sensitive and BFA-insensitive lipid trafficking pathways to define their contribution in SM acquisition during infection. We found that C. trachomatis hijacks components of both vesicular and non-vesicular lipid trafficking pathways for SM acquisition but that the SM obtained from these separate pathways is being utilized by the pathogen in different ways. We show that C. trachomatis selectively co-opts only one of the three known BFA targets, GBF1, a regulator of Arf1-dependent vesicular trafficking within the early secretory pathway for vesicle-mediated SM acquisition. The Arf1/GBF1-dependent pathway of SM acquisition is essential for inclusion membrane growth and stability but is not required for bacterial replication. In contrast, we show that C. trachomatis co-opts CERT, a lipid transfer protein that is a key component in non-vesicular ER to trans-Golgi trafficking of ceramide (the precursor for SM), for C. trachomatis replication. We demonstrate that C. trachomatis recruits CERT, its ER binding partner, VAP-A, and SM synthases, SMS1 and SMS2, to the inclusion and propose that these proteins establish an on-site SM biosynthetic factory at or near the inclusion. We hypothesize that SM acquired by CERT-dependent transport of ceramide and subsequent conversion to SM is necessary for C. trachomatis replication whereas SM acquired by the GBF1-dependent pathway is essential for inclusion growth and stability. Our results reveal a novel mechanism by which an intracellular pathogen redirects SM biosynthesis to its replicative niche.
Zdroje
1. SchachterJ 1988 The intracellular life of Chlamydia. Curr Topics Microbiol Immunol 138 109 139
2. CampbellLAKuoCC 2003 Chlamydia pneumoniae and atherosclerosis. Semin Respir Infect 18 48 54
3. HackstadtT 1999 Cell Biology. StephensR Chlamydia Washington, D.C. ASM press 101 138
4. CocchiaroJLValdiviaRH 2009 New insights into Chlamydia intracellular survival mechanisms. Cell Microbiol 11 1571 1578
5. ScidmoreMARockeyDDFischerERHeinzenRAHackstadtT 1996 Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. Infect Immun 64 5366 5372
6. HackstadtTRockeyDHeinzenRScidmoreM 1996 Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J 15 964 977
7. KumarYValdiviaRH 2008 Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 4 159 169
8. HybiskeKStephensRS 2007 Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A 104 11430 11435
9. CarabeoRAMeadDJHackstadtT 2003 Golgi-dependent transport of cholesterol to the Chlamydial inclusion. Proc Natl Acad Sci U S A 100 6771 6776
10. HackstadtTScidmoreMRockeyD 1995 Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci USA 92 4877 4881
11. SuHMcClartyGDongFHatchGMPanZK 2004 Activation of Raf/MEK/ERK/cPLA2 Signaling Pathway Is Essential for Chlamydial Acquisition of Host Glycerophospholipids. J Biol Chem 279 9409 9416
12. van OoijCvan IjzendoornSNishijimaMHanadaKMostovK 2000 Host derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis. Cell Microbiol 2 627 638
13. WylieJLHatchGMMcClartyG 1997 Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bacteriol 179 7233 7242
14. ScidmoreMAFischerERHackstadtT 1996 Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol 134 363 374
15. RobertsonDKGuLRoweRKBeattyWL 2009 Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis. PLoS Pathog 5 e1000664
16. CarabeoRCliftonDHackstadtT 2003 Rac Signaling to the Actin Machinery is Required for Invasion by Chlamydia trachomatis. American Society for Cell Biology Abstracts B357
17. HackstadtTRockeyDDHeinzenRAScidmoreMA 1996 Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J 15 964 977
18. HackstadtTScidmoreMARockeyDD 1995 Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A 92 4877 4881
19. BeattyWL 2008 Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63. Infect Immun 76 2872 2881
20. BeattyWL 2006 Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis. J Cell Sci 119 350 359
21. HeuerDRejman LipinskiAMachuyNKarlasAWehrensA 2009 Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature 457 731 735
22. Rejman LipinskiAHeymannJMeissnerCKarlasABrinkmannV 2009 Rab6 and Rab11 regulate Chlamydia trachomatis development and golgin-84-dependent Golgi fragmentation. PLoS Pathog 5 e1000615
23. HatchGMMcClartyG 1998 Phospholipid composition of purified Chlamydia trachomatis mimics that of the eukaryotic cell. Inf Immun 66 3727 3735
24. Lippincott-SchwartzJYuanLCBonifacinoJSKlausnerRD 1989 Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56 801 813
25. KlausnerRDDonaldsonJGLippincott-SchwartzJ 1992 Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116 1071 1080
26. BuiQTGolinelli-CohenMPJacksonCL 2009 Large Arf1 guanine nucleotide exchange factors: evolution, domain structure, and roles in membrane trafficking and human disease. Mol Genet Genomics 282 329 350
27. JacksonCLCasanovaJE 2000 Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors. Trends Cell Biol 10 60 67
28. CasanovaJE 2007 Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors. Traffic 8 1476 1485
29. MansourSJSkaugJZhaoXHGiordanoJSchererSW 1999 p200 ARF-GEP1: a Golgi-localized guanine nucleotide exchange protein whose Sec7 domain is targeted by the drug brefeldin A. Proc Natl Acad Sci U S A 96 7968 7973
30. TogawaAMorinagaNOgasawaraMMossJVaughanM 1999 Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors. J Biol Chem 274 12308 12315
31. NiuTKPfeiferACLippincott-SchwartzJJacksonCL 2005 Dynamics of GBF1, a Brefeldin A-sensitive Arf1 exchange factor at the Golgi. Mol Biol Cell 16 1213 1222
32. ZhaoXClaudeAChunJShieldsDJPresleyJF 2006 GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein traffic. J Cell Sci 119 3743 3753
33. ManoleaFClaudeAChunJRosasJMelanconP 2008 Distinct functions for Arf guanine nucleotide exchange factors at the Golgi complex: GBF1 and BIGs are required for assembly and maintenance of the Golgi stack and trans-Golgi network, respectively. Mol Biol Cell 19 523 535
34. ClaudeAZhaoBPKuziemskyCEDahanSBergerSJ 1999 GBF1: A novel Golgi-associated BFA-resistant guanine nucleotide exchange factor that displays specificity for ADP-ribosylation factor 5. J Cell Biol 146 71 84
35. KawamotoKYoshidaYTamakiHToriiSShinotsukaC 2002 GBF1, a guanine nucleotide exchange factor for ADP-ribosylation factors, is localized to the cis-Golgi and involved in membrane association of the COPI coat. Traffic 3 483 495
36. YamajiRAdamikRTakedaKTogawaAPacheco-RodriguezG 2000 Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex. Proc Natl Acad Sci U S A 97 2567 2572
37. SaenzJBSunWJChangJWLiJBursulayaB 2009 Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat Chem Biol 5 157 165
38. MyersKRCasanovaJE 2008 Regulation of actin cytoskeleton dynamics by Arf-family GTPases. Trends Cell Biol 18 184 192
39. StyersMLKowalczykAPFaundezV 2006 Architecture of the vimentin cytoskeleton is modified by perturbation of the GTPase ARF1. J Cell Sci 119 3643 3654
40. MoorheadAMJungJYSmirnovAKauferSScidmoreMA 2010 Multiple host proteins that function in phosphatidylinositol-4-phosphate metabolism are recruited to the chlamydial inclusion. Infect Immun 78 1990 2007
41. MehlitzABanhartSMaurerAPKaushanskyAGordusAG 2010 Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1. J Cell Biol 190 143 157
42. HanadaKKumagaiKTomishigeNYamajiT 2009 CERT-mediated trafficking of ceramide. Biochim Biophys Acta 1791 684 691
43. HanadaKKumagaiKYasudaSMiuraYKawanoM 2003 Molecular machinery for non-vesicular trafficking of ceramide. Nature 426 803 809
44. KumagaiKYasudaSOkemotoKNishijimaMKobayashiS 2005 CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem 280 6488 6495
45. KawanoMKumagaiKNishijimaMHanadaK 2006 Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J Biol Chem 281 30279 30288
46. HuitemaKvan den DikkenbergJBrouwersJFHolthuisJC 2004 Identification of a family of animal sphingomyelin synthases. EMBO J 23 33 44
47. HanadaK 2010 Intracellular trafficking of ceramide by ceramide transfer protein. Proc Jpn Acad Ser B Phys Biol Sci 86 426 437
48. KumagaiKKawanoMShinkai-OuchiFNishijimaMHanadaK 2007 Interorganelle trafficking of ceramide is regulated by phosphorylation-dependent cooperativity between the PH and START domains of CERT. J Biol Chem 282 17758 17766
49. FugmannTHausserASchofflerPSchmidSPfizenmaierK 2007 Regulation of secretory transport by protein kinase D-mediated phosphorylation of the ceramide transfer protein. J Cell Biol 178 15 22
50. SaitoSMatsuiHKawanoMKumagaiKTomishigeN 2008 Protein phosphatase 2Cepsilon is an endoplasmic reticulum integral membrane protein that dephosphorylates the ceramide transport protein CERT to enhance its association with organelle membranes. J Biol Chem 283 6584 6593
51. HanadaKKumagaiKTomishigeNKawanoM 2007 CERT and intracellular trafficking of ceramide. Biochim Biophys Acta 1771 644 653
52. WangENorredWPBaconCWRileyRTMerrilAH 1991 Inhibition of sphingolipid biosynthesis by fumonisins: implications for diseases associated with Fusarium moniliforme. J Biol Chem 266 14486 14490
53. ElwellCACeesayAKimJHKalmanDEngelJN 2008 RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog 4 e1000021
54. D'Souza-SchoreyCChavrierP 2006 ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7 347 358
55. ChandranSMachamerCE 2008 Acute perturbations in Golgi organization impact de novo sphingomyelin synthesis. Traffic 9 1894 1904
56. TafesseFGHuitemaKHermanssonMvan der PoelSvan den DikkenbergJ 2007 Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells. J Biol Chem 282 17537 17547
57. MajeedMKrauseKHClarkRAKihlstromEStendahlO 1999 Localization of intracellular Ca2+ stores in HeLa cells during infection with Chlamydia trachomatis. J Cell Sci 112 Pt 1 35 44
58. GilesDKWyrickPB 2008 Trafficking of chlamydial antigens to the endoplasmic reticulum of infected epithelial cells. Microbes Infect 10 1494 1503
59. YasudaSKitagawaHUenoMIshitaniHFukasawaM 2001 A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis. J Biol Chem 276 43994 44002
60. KudoNKumagaiKMatsubaraRKobayashiSHanadaK 2010 Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer. J Mol Biol 396 245 251
61. TomishigeNKumagaiKKusudaJNishijimaMHanadaK 2009 Casein kinase I{gamma}2 down-regulates trafficking of ceramide in the synthesis of sphingomyelin. Mol Biol Cell 20 348 357
62. LubertoCHannunYA 1998 Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J Biol Chem 273 14550 14559
63. LiZHailemariamTKZhouHLiYDuckworthDC 2007 Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochim Biophys Acta 1771 1186 1194
64. PerryRJRidgwayND 2004 The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609. J Lipid Res 45 164 173
65. CowartLASzulcZBielawskaAHannunYA 2002 Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies. J Lipid Res 43 2042 2048
66. HanadaKHaraTFukasawaMYamajiAUmedaM 1998 Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase. J Biol Chem 273 33787 33794
67. ShinHWNakayamaK 2004 Dual control of membrane targeting by PtdIns(4)P and ARF. Trends Biochem Sci 29 513 515
68. FengYYuSLasellTKJadhavAPMaciaE 2003 Exo1: a new chemical inhibitor of the exocytic pathway. Proc Natl Acad Sci U S A 100 6469 6474
69. TaniMKugeO 2009 Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail, which is involved in its localization in plasma membranes. Biochem Biophys Res Commun 381 328 332
70. BrumellJHScidmoreMA 2007 Manipulation of rab GTPase function by intracellular bacterial pathogens. Microbiol Mol Biol Rev 71 636 652
71. Prinz WA Lipid Trafficking sans Vesicles: Where, Why, How? Cell 143 870 874
72. WangXRaoRPKosakowska-CholodyTMasoodMASouthonE 2009 Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. J Cell Biol 184 143 158
73. RaoRPYuanCAllegoodJCRawatSSEdwardsMB 2007 Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc Natl Acad Sci U S A 104 11364 11369
74. SoniKGMardonesGASougratRSmirnovaEJacksonCL 2009 Coatomer-dependent protein delivery to lipid droplets. J Cell Sci 122 1834 1841
75. GuoYWaltherTCRaoMStuurmanNGoshimaG 2008 Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature 453 657 661
76. KumarYCocchiaroJValdiviaRH 2006 The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol 16 1646 1651
77. CocchiaroJLKumarYFischerERHackstadtTValdiviaRH 2008 Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci U S A 105 9379 9384
78. NagaiHKaganJCZhuXKahnRARoyCR 2002 A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science 295 679 682
79. AmorJCSwailsJZhuXRoyCRNagaiH 2005 The structure of RalF, an ADP-ribosylation factor guanine nucleotide exchange factor from Legionella pneumophila, reveals the presence of a cap over the active site. J Biol Chem 280 1392 1400
80. RzompKAScholtesLDBriggsBJWhittakerGRScidmoreMA 2003 Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect Immun 71 5855 5870
81. Dumaresq-DoironKSavardMFAkamSCostantinoSLefrancoisS 2010 The phosphatidylinositol 4-kinase PI4KIIIalpha is required for the recruitment of GBF1 to Golgi membranes. J Cell Sci 123 2273 2280
82. ZhaoXLasellTKMelanconP 2002 Localization of large ADP-ribosylation factor-guanine nucleotide exchange factors to different Golgi compartments: evidence for distinct functions in protein traffic. Mol Biol Cell 13 119 133
83. ChunJShapovalovaZDejgaardSYPresleyJFMelanconP 2008 Characterization of class I and II ADP-ribosylation factors (Arfs) in live cells: GDP-bound class II Arfs associate with the ER-Golgi intermediate compartment independently of GBF1. Mol Biol Cell 19 3488 3500
84. BelovGAFengQNikovicsKJacksonCLEhrenfeldE 2008 A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS Pathog 4 e1000216
85. van OoijCApodacaGEngelJ 1997 Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect Immun 65 758 766
86. CaldwellHDKromhoutJSchachterJ 1981 Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infection and Immunity 31 1161 1176
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 9
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Hostile Takeover by : Reorganization of Parasite and Host Cell Membranes during Liver Stage Egress
- HTLV-1 Propels Thymic Human T Cell Development in “Human Immune System” Rag2 gamma c Mice
- Exploiting and Subverting Tor Signaling in the Pathogenesis of Fungi, Parasites, and Viruses
- A Viral Ubiquitin Ligase Has Substrate Preferential SUMO Targeted Ubiquitin Ligase Activity that Counteracts Intrinsic Antiviral Defence